Theresa A Deisher
Principal investigator.
Biotech
Built from public records only: federal awards, patents, filings and papers.Is this you? Contact Noair Lab to claim this profile, correct it or hide it.
2019First federal award
$5.5MFederal grants as PI8 awards
1Patents grantedLatest Jul 24, 2018
0PapersOpenAlex
Federal awards and patents by year
AwardsPatents
8 awards · $5.5M
| Date | Agency | Award | Amount | Company |
|---|---|---|---|---|
| Sep 8, 2025 | NIH | SBIR Phase II Immunomodulatory AVM0703 to bridge Relapsed/Refractory Diffuse Large B-Cell Lymphoma patients to CAR-T cell immunotherapy | $992K | Avm Biotechnology, LLC |
| May 10, 2023 | NIH | SBIR Phase II Expedited Expansion Cohort Clinical Trial for Relapsed/Refractory 'no-option' Non-Hodgkin's Lymphoma/Leukemia Patients | $1000K | Avm Biotechnology, LLC |
| Mar 30, 2023 | NIH | SBIR Phase II Targeted Lymphoablation as an alternative to HSCT to cure T1D | $964K | Avm Biotechnology, LLC |
| Aug 5, 2022 | NIH | SBIR Phase I AVM0703 combined with Non-Hodgkin's Lymphoma standard of care to enhance complete response rates without additional toxicities | $399K | Avm Biotechnology, LLC |
| Jun 10, 2022 | NIH | SBIR Phase II Expedited Expansion Cohort Clinical Trial for Relapsed/Refractory 'no-option' Non-Hodgkin's Lymphoma/Leukemia Patients | $1000K | Avm Biotechnology, LLC |
| Mar 30, 2022 | NIH | SBIR Phase II Targeted Lymphoablation as an alternative to HSCT to cure T1D | $668K | Avm Biotechnology, LLC |
| May 29, 2020 | NIH | SBIR Phase I A novel non-toxic preconditioning regimen for cancer cell therapy | $225K | Avm Biotechnology, LLC |
| Sep 19, 2019 | NIH | SBIR Phase I Targeted lympho-ablation as an alternative to HSCT to cure T1D | $211K | Avm Biotechnology, LLC |
1 patents as inventor
- US 10030230Avm Biotechnology, LLCJul 24, 2018
Matched by the first inventor’s name and the patent’s company.
Peer ranks
Federal funding#233
Awards as PI#190
Patents#155
Companies
- Avm Biotechnology, LLCLinked by awards · Biotech
Federal awards through Oct 21, 2026 and patents through Oct 20, 2026. Awards come from NIH, NSF and other agency records that name a principal investigator; DoD and NASA contract awards do not, so they are not shown here. Researchers are matched by name and company.